InterVenn Biosciences: Erwin Estigarribia, Laura Beggrow

InterVenn Biosciences has appointed Erwin Estigarribia its CEO and Laura Beggrow its chief commercial officer. Estigarribia was previously Intervenn's president and chief operating officer, and prior to joining the company, he held executive level positions at Nugen, CardioDX, and Applied Proteomics. Beggrow previously held executive leadership positions at HTG Molecular, Celcuity, NantHealth, and Strand Diagnostics. She was also VP of sales and diagnostics at Genomic Health from 2004 to 2013.